ARF like GTPase 8B (Ensembl:ADP-ribosylation factor like GTPase 8B)
RGD ID:
1562830
Description:
Predicted to enable G protein activity; guanyl ribonucleotide binding activity; and tubulin binding activity. Predicted to be involved in several processes, including antigen processing and presentation following phagocytosis; cytosolic transport; and vesicle fusion. Predicted to act upstream of or within endosomal transport. Predicted to be located in several cellular components, including cytolytic granule membrane; midbody; and spindle midzone. Predicted to be active in early endosome membrane and lysosomal membrane. Orthologous to human ARL8B (ARF like GTPase 8B); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol; bisphenol A.
ADP-ribosylation factor like GTPase 8B; ADP-ribosylation factor-like 8B; ADP-ribosylation factor-like protein 8B; LOC500282; similar to ADP-ribosylation factor-like 10C
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ARL8B more ...
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...